中國鐵建(01186.HK)完成發行35億元票據
格隆匯9月15日丨中國鐵建(01186.HK)公吿,於2024年9月13日,公司、公司的間接全資附屬公司鐵建華源有限公司為發行人與華泰國際、工商銀行、星展銀行有限公司、中國農業銀行股份有限公司、中國銀行(香港)、交通銀行、中國建設銀行(亞洲)、中信銀行(國際)及招銀國際就發行及認購本金總額為人民幣35億元的票據訂立認購協議。
票據的發行所得款項淨額約為人民幣34.97億元。發行人擬將所得款項淨額用於償還到期債務及補充境外承建工程項目流動資金。與本次發售所得款項淨額相等的金額將全部或部分用於為公司可持續金融框架下的現有合資格項目提供資金及╱或再融資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.